Does early antipsychotic response predict long-term treatment outcome?

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Neuroscience

Background:

• Early antipsychotic response is a known predictor of short-term outcomes in psychosis.
• The persistence of this predictive value over multiple years remains less understood.

Purpose of the Study:

• To investigate if early antipsychotic response predicts long-term outcomes in patients with first-episode psychosis.
• To determine if the predictive value of early response differs between haloperidol and olanzapine.

Main Methods:

• Observational study with 64 first-episode psychosis patients followed for an average of 25 months.
• Regression analyses assessed if early improvement on the Brief Psychiatric Rating Scale (BPRS) predicted long-term improvement.
• Secondary analyses examined prediction of extrapyramidal side effects.

Main Results:

• Early haloperidol response at 2 weeks significantly predicted long-term BPRS improvement (p = .002).
• Early olanzapine response at 2 or 3 weeks did not predict long-term improvement (p > .05).
• No significant differences in extrapyramidal side effects or their prediction by early response were found.

Conclusions:

• Early response to haloperidol demonstrates significant long-term prognostic value in first-episode psychosis.
• The predictive utility of early olanzapine response for long-term outcomes appears less robust compared to haloperidol.